AC625 amylin blocker: Started a Phase I trial

Amylin Pharmaceuticals Inc. (AMLN), San Diego Product: AC625 amylin blocker Indication: Treatment of high blood pressure in overweight patients at risk of becoming diabetic Status: Started a Phase I t...